Keyphrases
Myasthenia Gravis
86%
Experimental Autoimmune Myasthenia Gravis
60%
Acetylcholine Receptor (AChR)
42%
Ischemia-reperfusion Injury
34%
B Cells
30%
Inflammatory Response
30%
IgG1
29%
Autoantibodies
28%
Reperfusion
28%
Small Interfering RNA (siRNA)
24%
Sepsis
22%
Skeletal muscle
22%
Mouse Model
21%
Interleukin-6
21%
Neuromuscular Junction
19%
Histone Deacetylase 1 (HDAC1)
19%
Ovine
19%
Myasthenia
19%
Smoke Inhalation
17%
Intercellular Adhesion molecule-1 (ICAM-1)
17%
Acetylcholine Receptor Antibody
16%
Muscle Weakness
15%
Manganese Superoxide Dismutase (MnSOD)
15%
Interleukin-8
15%
Autoimmune Disease
15%
Inflammation
13%
Tumor Necrosis Factor-α
13%
Ascites
12%
Respiratory Syncytial Virus
12%
Immunization
12%
Receptor-interacting Protein Kinase 1 (RIPK1)
12%
Specific Receptor
12%
Human muscle
12%
Interleukin-4 (IL-4)
11%
Interleukin-10
11%
Complement System
11%
Tourniquet
11%
Cytokine Production
11%
Acute Lung Injury
10%
Complement C2
9%
Ceftazidime
9%
Respiratory Viruses
9%
Therapeutic Strategies
9%
Remote Ischemic Preconditioning
9%
Mouse Heart
9%
BAFF-R
9%
B-cell Lymphoma
9%
Acute Flaccid Myelitis
9%
Non-selective
9%
Preferential Accumulation
9%
Immunology and Microbiology
Myasthenia gravis
100%
Experimental Autoimmune Myasthenia Gravis
63%
Autoantibodies
43%
B Cell
39%
Immunology
35%
Mouse Model
31%
Reperfusion
30%
Immunoglobulin G1
26%
Interleukin 6
24%
Skeletal Muscle
22%
Neuromuscular Junction
20%
Cytokine
18%
Tumor Necrosis Factor
16%
Isotype
16%
Signal Transduction
14%
Autoimmune Disease
14%
Superoxide
14%
Interleukin 8
13%
Human Respiratory Syncytial Virus
12%
B Cell Activating Factor Receptor
12%
Conjugate
12%
Viral Disease
11%
Interleukin 4
11%
Blood Plasma
11%
Gene Expression
11%
Complement System
11%
Intercellular Adhesion Molecule 1
11%
Cytokine Production
11%
Influenza Virus
11%
Macrophage
10%
Neutrophil Granulocyte
10%
Complement Component 2
9%
Ischemic Preconditioning
9%
Mesenteric Artery
9%
IgG Deficiency
9%
Respiratory Virus
9%
Bagg Albino Mouse
9%
Transgenic Mouse
9%
Human Leukocyte Antigen
9%
Ocular Myasthenia
9%
Cell Line
9%
Promoter Region
9%
Lymph Node
9%
Drug Megadose
9%
Methicillin-Resistant Staphylococcus Aureus
9%
Ovine Model
9%
Immunoglobulin G1 Antibody
9%
Lymphocyte
9%
Interleukin 10
9%
Immunoassay
9%
Medicine and Dentistry
Sepsis
19%
Smoke Inhalation
13%
Serositis
10%
Ischemia
10%
Diagnosis
9%
Connective Tissue Cancer
9%
Methicillin Resistant Staphylococcus Aureus
9%
Nitric Oxide
9%
Lymphocyte
9%
Drotrecogin Alfa
9%
Cell Adhesion Molecule 1
9%
Transverse Myelitis
9%
Influenza Virus
9%
Acute Lung Injury
9%
Lung Function
9%
Myasthenia gravis
9%
Cell Line
9%
B Cell
9%
Virus Infection
9%
Ascites
9%
Porphyria
9%
Porphyrin
7%
Interleukin 6
7%
Manganese Superoxide Dismutase
7%
Interleukin 8
7%
